Galmed Pharmaceuticals Ltd (GLMD) — Tangible Net Worth Ratio
Galmed Pharmaceuticals Ltd (GLMD) has a Tangible Net Worth Ratio of 63.6% as of June 2026. This metric is calculated by deducting intangible assets ($4.64 Million) from net assets ($12.74 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Galmed Pharmaceuticals Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Galmed Pharmaceuticals Ltd Tangible Net Worth Ratio (2014–2025)
This chart shows how Galmed Pharmaceuticals Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 63.6%, reflecting net assets of $12.74 Million with intangible assets of $4.64 Million USD. For live market cap and overall valuation, see market cap of Galmed Pharmaceuticals Ltd.
Annual Tangible Net Worth Ratio for Galmed Pharmaceuticals Ltd (2014–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Galmed Pharmaceuticals Ltd from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See financial agility of Galmed Pharmaceuticals Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $15.78 Million | $0.00 | $18.63 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $16.33 Million | $0.00 | $18.50 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $13.88 Million | $0.00 | $16.63 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $13.42 Million | $0.00 | $16.56 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $30.50 Million | $0.00 | $36.60 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $44.15 Million | $0.00 | $52.38 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $69.85 Million | $0.00 | $77.14 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $87.89 Million | $0.00 | $90.60 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $15.79 Million | $0.00 | $19.64 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $11.07 Million | $0.00 | $16.45 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $21.55 Million | $0.00 | $24.26 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $31.41 Million | $0.00 | $32.92 Million | — |